SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-101852"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-101852" > The neuropeptide Y ...

The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice

Karlsson, Rose-Marie (författare)
National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, USA
Choe, Jessica S. (författare)
National Institute of Mental Health, NIH, Bethesda, MD, USA
Cameron, Heather A (författare)
National Institute of Mental Health, NIH, Bethesda, MD, USA
visa fler...
Thorsell, Annika (författare)
National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, USA
Crawley, Jacqueline N (författare)
National Institute of Mental Health, NIH, Bethesda, MD, USA
Holmes, Andrew (författare)
National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, USA
Heilig, Markus (författare)
National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, USA
visa färre...
 (creator_code:org_t)
2007-09-22
2008
Engelska.
Ingår i: Psychopharmacology. - : Springer. - 0033-3158 .- 1432-2072. ; 195:4, s. 547-557
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • RATIONALE: Neuropeptide Y (NPY) is implicated in the pathophysiology of affective illness. Multiple receptor subtypes (Y1R, Y2R, and Y5R) have been suggested to contribute to NPY's effects on rodent anxiety and depression-related behaviors.OBJECTIVES: To further elucidate the role of Y1R in (1) NPY's anxiolytic-like effects and (2) fluoxetine's antidepressant-like and neurogenesis-inducing effects.METHODS: Mice lacking Y1R were assessed for spontaneous anxiety-like behavior (open field, elevated plus-maze, and light/dark exploration test) and Pavlovian fear conditioning, and for the anxiolytic-like effects of intracerebroventricularly (icv)-administrated NPY (elevated plus-maze). Next, Y1R -/- were assessed for the antidepressant-like effects of acute fluoxetine in the forced swim test and chronic fluoxetine in the novelty-induced hypophagia test, as well as for chronic fluoxetine-induced hippocampal neurogenesis.RESULTS: Y1R -/- exhibited largely normal baseline behavior as compared to +/+ littermate controls. Intraventricular administration of NPY in Y1R -/- mice failed to produce the normal anxiolytic-like effect in the elevated plus-maze test seen in +/+ mice. Y1R mutant mice showed higher immobility in the forced swim test and longer latencies in the novelty-induced hypophagia test. In addition, Y1R -/- mice responded normally to the acute and chronic effects of fluoxetine treatment in the forced swim test and the novelty-induced hypophagia test, respectively, as well as increased neuronal precursor cell proliferation in the hippocampus.CONCLUSIONS: These data demonstrate that Y1R is necessary for the anxiolytic-like effects of icv NPY, but not for the antidepressant-like or neurogenesis-inducing effects of fluoxetine. The present study supports targeting Y1R as a novel therapeutic target for anxiety disorders.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Nyckelord

Neuropeptide Y
Y1
Receptor
Knockout
Mouse
Fear
Anxiety
Depression
Neurogenesis

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy